Valuation eFFECTOR Therapeutics, Inc. BOERSE MUENCHEN
Stocks
LWK
US28202V2079
Biotechnology & Medical Research
|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-.--% | - |
| 10/09/24 | Tyra Biosciences Names Doug Warner Chief Medical Officer | MT |
| 08/07/24 | EFFECTOR Therapeutics, Inc.(OTCPK:EFTR) dropped from S&P TMI Index | CI |
Company Valuation: eFFECTOR Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Market Cap 1 | 334.3 | 17.91 | 30.2 |
| Change | - | -94.64% | 68.61% |
| Enterprise Value (EV) 1 | 304.6 | 11.88 | 32.38 |
| Change | - | -96.1% | 172.45% |
| P/E | 18.8x | -0.78x | -0.71x |
| PBR | 19.3x | 4.58x | -6.01x |
| PEG | 0x | 0x | -0x |
| Capitalization / Revenue | 233,760,757x | 5,041,796x | - |
| EV / Revenue | - | - | - |
| EV / EBITDA | -9.56x | -0.37x | -0.96x |
| EV / EBIT | -9.55x | -0.37x | -0.96x |
| EV / FCF | - | - | - |
| FCF Yield | - | - | - |
| Dividend per Share 2 | - | - | - |
| Rate of return | - | - | - |
| EPS 2 | 11 | -13.76 | -16.37 |
| Distribution rate | - | - | - |
| Net sales | 1.43 | 3.553 | - |
| EBITDA 1 | -31.87 | -32.35 | -33.73 |
| EBIT 1 | -31.9 | -32.4 | -33.84 |
| Net income 1 | 15.8 | -22.66 | -35.81 |
| Net Debt 1 | -29.67 | -6.029 | 2.175 |
| Reference price 2 | 207.000000 | 10.690000 | 11.685000 |
| Nbr of stocks (in thousands) | 1,615 | 1,676 | 2,585 |
| Announcement Date | 3/16/22 A | 3/8/23 A | 3/26/24 A |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 21.25x | 6.51x | 14.24x | 1.5% | 56.54B | ||
| 31.6x | 7.8x | 24.02x | 0.05% | 53.6B | ||
| -17.91x | 4.18x | -7.32x | -.--% | 22.91B | ||
| -38.06x | 12.21x | -36.05x | -.--% | 21.37B | ||
| 25.45x | 4.98x | 13.18x | -.--% | 20.27B | ||
| 24.28x | 4.73x | 15.36x | -.--% | 17.56B | ||
| -737.38x | 35.03x | -3943.97x | -.--% | 14.75B | ||
| 40.7x | 16.37x | 42.16x | 0.09% | 13.53B | ||
| 16.73x | 4.82x | 11.24x | -.--% | 13.33B | ||
| Average | -70.37x | 10.74x | -429.68x | 0.18% | 25.98B | |
| Weighted average by Cap. | -32.01x | 9.11x | -238.39x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- EFTR Stock
- LWK Stock
- Valuation eFFECTOR Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
















